loader
Find a Test

Fragile X Syndrome

Order Code
481701
CPT
81243
Test Details
Synonyms

Fragile X-associated primary ovarian insufficiency (FXPOI)

TAT

18 days (In some cases, additional time may be required for confirmatory or reflex tests.)

Methodology

Polymerase chain reaction (PCR) followed by capillary electrophoresis, methylation PCR analysis and reflex to AGG interruption analysis when appropriate

Remarks

Special Instructions To test foetal specimens, including cord blood, order test code 481718, Fragile X Syndrome, Foetal Analysis. Cause for Rejection: Frozen or haemolysed specimen, quantity not sufficient for analysis, improper container.

Performing Location

Accredited Laboratory Partner

Testing Frequency

Contact Technical Support

Test Overview

Genetic analysis used to diagnose Fragile X Syndrome, a leading cause of inherited intellectual disability and autism spectrum disorders. It detects mutations in the FMR1 gene, particularly CGG repeat expansions, which lead to gene silencing and reduced protein production necessary for normal brain development.

Specimen Type

Whole Blood or PurFlock buccal swab kit or oragene Dx saliva kit

Volume

8.5 mL whole blood or PurFlock buccal swab kit or Oragene Dx saliva kit

Specimen Container

Yellow-top (ACD-A), lavender-top (EDTA), pink-top (EDTA) or tan-top (EDTA) tubes, or PurFlock buccal swab kit or Oragene Dx 500 saliva collection kit

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.

Collection

Standard phlebotomy. Follow PurFlock buccal swab kit or Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection.

Specimen Stability
Temperature Period
Room temperature Whole blood: 14 days Buccal: 60 days Saliva: 60 days
Refrigerated Whole blood: 30 days
Order Code
481701
CPT
81243
Test Details
Synonyms

Fragile X-associated primary ovarian insufficiency (FXPOI)

TAT

18 days (In some cases, additional time may be required for confirmatory or reflex tests.)

Methodology

Polymerase chain reaction (PCR) followed by capillary electrophoresis, methylation PCR analysis and reflex to AGG interruption analysis when appropriate

Remarks

Special Instructions To test foetal specimens, including cord blood, order test code 481718, Fragile X Syndrome, Foetal Analysis. Cause for Rejection: Frozen or haemolysed specimen, quantity not sufficient for analysis, improper container.

Performing Location

Accredited Laboratory Partner

Testing Frequency

Contact Technical Support

Test Overview

Genetic analysis used to diagnose Fragile X Syndrome, a leading cause of inherited intellectual disability and autism spectrum disorders. It detects mutations in the FMR1 gene, particularly CGG repeat expansions, which lead to gene silencing and reduced protein production necessary for normal brain development.

Specimen Type

Whole Blood or PurFlock buccal swab kit or oragene Dx saliva kit

Volume

8.5 mL whole blood or PurFlock buccal swab kit or Oragene Dx saliva kit

Specimen Container

Yellow-top (ACD-A), lavender-top (EDTA), pink-top (EDTA) or tan-top (EDTA) tubes, or PurFlock buccal swab kit or Oragene Dx 500 saliva collection kit

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.

Collection

Standard phlebotomy. Follow PurFlock buccal swab kit or Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection.

Specimen Stability
Temperature Period
Room temperature Whole blood: 14 days Buccal: 60 days Saliva: 60 days
Refrigerated Whole blood: 30 days